Target intelligence / Profile preview

Various lipid-metabolizing pathways and membrane lipids

Molecular classification
Metabolic pathway, Lipid, Enzyme, Structural component
01

Overview

The term Various lipid-metabolizing pathways and membrane lipids refers to a broad collection of biochemical processes and structural molecules rather than a single therapeutic target. Lipid-metabolizing pathways encompass the enzymatic networks responsible for the synthesis, transport, and degradation of lipids, which are critical for energy homeostasis and the production of signaling molecules like eicosanoids (StatPearls, Lipid Metabolism, 2023). Membrane lipids, including phospholipids, sphingolipids, and sterols, provide the essential structural framework for cellular membranes and modulate the activity of membrane-bound proteins (Molecular Biology of the Cell, 4th ed., 2002). Pharmacological intervention in these areas is diverse, involving the inhibition of specific enzymes such as HMG-CoA reductase by statins or the direct binding to membrane components like ergosterol by antifungal agents (PubChem, Atorvastatin; PubChem, Amphotericin B). Because this designation aggregates hundreds of distinct enzymes and structural lipids with varied biological roles, it is classified as a general category or descriptive phrase rather than a specific, actionable molecular target for drug discovery (IUPHAR/BPS Guide to Pharmacology).

Other names
Lipid metabolismMembrane lipid componentsLipid signaling pathwaysLipid homeostasis
02

Mechanism of action

Modulation of lipid homeostasis through the inhibition of specific biosynthetic enzymes or direct physical interaction with lipid bilayer components to alter membrane permeability and function.

03

Biological functions

Energy storageCell signalingMembrane integrityHormone synthesisCellular compartmentalization
04

Disease associations

DyslipidemiaAtherosclerosisMetabolic syndromeCancerInfectionNeurodegenerative disease
05

Safety considerations

HepatotoxicityMyopathy and rhabdomyolysisGastrointestinal malabsorptionElectrolyte imbalancesPotential for off-target disruption of human cell membranes
06

Interacting drugs

Atorvastatin

5 more in the full profile.

07

Biomarkers

Low-density lipoprotein (LDL) cholesterolHigh-density lipoprotein (HDL) cholesterolTotal triglyceridesApolipoprotein BC-reactive protein

Beyond the preview

Go deeper on Various lipid-metabolizing pathways and membrane lipids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Various lipid-metabolizing pathways and membrane lipids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call